Healthequity (HQY) Change in Receivables (2013 - 2026)

Healthequity's Change in Receivables history runs 14 years deep, the most recent figure standing at -$1.7 million for Q2 2026.

• In Q2 2026, Change in Receivables rose 3.26% year-over-year to -$1.7 million; the TTM figure through Apr 2026 stood at $5.7 million (down 42.75% YoY), while the FY2026 annual figure was $5.7 million, down 56.61% from the prior year.
• Change in Receivables was -$1.7 million for Q2 2026 at Healthequity, down from $12.5 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $12.5 million in Q1 2026 to a low of -$5.8 million in Q3 2023.
• Historically, Change in Receivables has averaged $2.0 million across 5 years, with a median of $1.2 million in 2022.
• Biggest YoY gain for Change in Receivables was 1971.84% in 2022; the steepest drop was 400.0% in 2022.
• A 5-year view of Change in Receivables shows it stood at -$2.7 million in 2022, then surged by 232.84% to $3.6 million in 2023, then plunged by 148.39% to -$1.7 million in 2024, then surged by 104.54% to $79000.0 in 2025, then slumped by 2243.04% to -$1.7 million in 2026.
• The last three Change in Receivables figures came in at -$1.7 million (Q2 2026), $12.5 million (Q1 2026), and $79000.0 (Q4 2025), per Business Quant data.